Vycor Medical (VYCO) Income towards Parent Company (2010 - 2026)
Vycor Medical's (VYCO) quarterly Income towards Parent Company came in at $13.0 in Q1 2026, up 126.53% year-on-year from $5.74 in Q1 2025, and up 104.23% on a QoQ basis from -$307.0 in Q4 2025.
Vycor Medical (VYCO) Income towards Parent Company (2010 - 2026) Analysis & Trends
Vycor Medical (VYCO) has 17 years of Income towards Parent Company data on file, last reported at $13.0 in Q1 2026.
- On a quarterly basis, Income towards Parent Company rose 126.53% year-over-year to $13.0 in Q1 2026; TTM through Mar 2026 was -$2174.0, a 1003.55% decrease from a year earlier, with the FY2025 full-year figure at -$2236.0, down 797.99% from the prior year.
- Income towards Parent Company for Q1 2026 stood at $13.0, up from -$307.0 in the prior quarter.
- Over the last five years, Income towards Parent Company for VYCO reached as high as $13.0 in Q1 2026 and fell as low as -$3094.0 in Q4 2023.
- Historically, Income towards Parent Company has averaged -$840.88 across 5 years, with a median of -$425.0 in 2023.
- Across the five-year window, Income towards Parent Company plunged 3626.53% in 2025 and surged 126.53% in 2026, its largest moves.
- Year by year, Income towards Parent Company stood at -$678.0 in 2022, then sank by 356.34% to -$3094.0 in 2023, then jumped by 98.32% to -$52.0 in 2024, then plunged by 490.38% to -$307.0 in 2025, then surged by 104.23% to $13.0 in 2026.
- Per Business Quant data, the three most recent Income towards Parent Company figures were $13.0 in Q1 2026, -$307.0 in Q4 2025, and -$54.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 182.32 Bn | 175.02 Bn | 6.27 Bn |
| 2 | Stryker | 128.75 Bn | 125.88 Bn | 3.81 Bn |
| 3 | Medtronic | 107.83 Bn | 98.61 Bn | 6.41 Bn |
| 4 | Boston Scientific | 67.61 Bn | 66.15 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 48.13 Bn | 44.45 Bn | 1.29 Bn |
| 6 | Dexcom | 28.26 Bn | 27.14 Bn | 750.30 Mn |
| 7 | GE HealthCare Technologies | 27.78 Bn | 25.50 Bn | 1.98 Bn |
| 8 | Smith & Nephew | 26.99 Bn | 26.41 Bn | - |
| 9 | Koninklijke Philips | 23.92 Bn | 20.80 Bn | 2.07 Bn |
| 10 | Vycor Medical | 2.34 Mn | 2.16 Mn | 375,153.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 13.00 |
| Dec 31, 2025 | -307.00 |
| Sep 30, 2025 | -54.00 |
| Jun 30, 2025 | -1,826.00 |
| Mar 31, 2025 | -49.00 |
| Dec 31, 2024 | -52.00 |
| Sep 30, 2024 | -47.00 |
| Jun 30, 2024 | -49.00 |
| Mar 31, 2024 | -101.00 |
| Dec 31, 2023 | -3,094.00 |
| Sep 30, 2023 | -425.00 |
| Jun 30, 2023 | -2,385.00 |
| Mar 31, 2023 | -707.00 |
| Dec 31, 2022 | -678.00 |
| Sep 30, 2022 | -2,495.00 |
| Jun 30, 2022 | -1,284.00 |
| Mar 31, 2022 | -755.00 |
| Dec 31, 2021 | -958.00 |
| Sep 30, 2021 | -3,966.00 |
| Jun 30, 2021 | -10,317.00 |